Archived Announcements

25-Aug-17 Genetic Technologies Announces Comprehensive Review of Strategic
Alternatives download
1-Aug-17 Genetic Technologies Launches Breast Cancer Awareness Month
Promotion for BREVAGenplus® download
21-July-17 Genetic Technologies Receives Nasdaq Deficiency Notice download
25-May-17 Appendix 3Y download
31- March -17 Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus® download
29-March-17 Genetic Technologies and IndyCar’s Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus® download
20-Feb-17 Employee Share Options Issued and Forfeited download
6-Dec-16 Cleansing notice under section 708A the Corporations Act 2001 (Cth) download
6-Dec-16 Capital Raising Update – Appendix 3B download
2-Dec-16 Genetic Technologies Announces AUD 8.1 million Capital Raising download
29-Nov-16 Exclusive License Agreement To Develop Colorectal Cancer Risk Assessment Test download
23-Nov-16 -16 2016 Annual General Meeting Results download
23-Nov-16 -16 2016 Annual General Meeting Presentation download
24-Oct-16 Notice of 2016 Annual General Meeting and Sample Proxy download
3-Oct-16 Genetic Technologies Launches BREVAGenplus® Marketing Program
Around Susan G. Komen®’s Race for the Cure® Events download
30-Aug-2016 Appendix 4E & Financial Report 2016 download
30-Aug-2016 Appendix 4G and Corporate Governance Statement 2016 download
22-June-16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann Update BREVAGenplus® Marketing Partnership download
21-June-16 Appointment of Senior Medical Director download
4-May-16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to
Ring Nasdaq Stock Market Closing Bell on May 6th, 2016 download
6-April-16 Appendix 3B download
6-April -16 Lapse of Share Options download
22-Feb-16 Genetic Technologies and IndyCar’s Pippa Mann Announce Partnership to
Promote BREVAGenplus® download
5-Feb-16 Settlement and Release Agreement with Hendrix Genetics B.V. download
13-Jan-16 Changes to Company Secretary download
21-Dec-15 Genetic Technologies Announces Publication of Key scientific Validation Results in Support of BREVAGenplus download
15-Dec-15 Appendix 3Y download
15-Dec-15 Appendix 3B download
25-Nov-15 Results from 2015 Annual General Meeting download
25-Nov -15 2015 Annual General Meeting download
23-Nov-15 Genetic Technologies Announces Publication Validating BREVAGenplus Testing for African-American and Hispanic Women download
02-Nov-15 Appendix 3Y download
29-Oct-15 Appendix 4C download
27-Oct-15 Notice of AGM and Sample Proxy download
06-Oct-15 CFO Transition download
24-Sep-15 Appendix 4G and Corporate Governance Statement download
28-Aug-15 Lapse of Options download
06-Aug-15 US Patent Office Grants Key BREVAGENplus® download
31-July-15 Appendix 4C download
23-July-15 Appendix 3B download
14-July-15 Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review Publication Initiatives download
09-July-15 Appointment of Joint Company Secretary download
15-June-15 Appointment of Chief Financial Officer download
12-June-15 Appointment of Executive Director download
29-May-15 Genetic Technologies supports research findings: Clinical validation is needed for gene-panel sequencing associated with hereditary breast cancer risk download
04-May-15 Second of Two Nasdaq Deficiencies Successfully Remediated download
23-April-15 Appendix 3Y download
20-April-15 Additional Breast Health Centres To Begin Offering BREVAGENplus download
01-April-15 Appendix 3Y download
13-March-15 Supplementary Prospectus download
12-Mar-15 Cleansing Notice Under Section 708A the Corporations Act 2001 (Cth) download
11-Mar-15 Capital Raising Update and Appendix 3B download
6-Mar-15 Genetic Technologies Announces AUD$18.6million Capital Raising download
6-Mar-15 Results from 2015 Extraordinary General Meeting download
26-Feb-15 Appointment of CEO download
24-Feb-15 Appendix 3B download
20-Feb-15 Appendix 3B download
19-Feb-15 Appendix 3B download
18-Feb-15 Appendix 3B download
13-Feb-15 Appendix 3B download
12-Feb-15 Appendix 3Y and 3Z download
9-Feb-15 Appendix 3B download
4-Feb-15 Notice of Extraordinary General Meeting and Sample Proxy Form download
4-Feb-15 NASDAQ Deficiencies Remediated download
2-Feb-15 Appendix 3B download
30-Jan-15 Appendix 3B  download
29-Jan-15 Up to 6 New Breast Centres to being offering BREVAGENplus download
28-Jan-15 Tribute to Mr David Carter download
22-Jan-15 Appendix 3B  download
22-Jan-15 Prospectus  download
22-Jan-15 Genetic Technologies secures A$24million Standby Equity Placement Facility  download
9-Jan-15 Appendix 3B  download
30-Dec-14 ASX Announcement – SPP Results download
30-Dec-14 Appendix 3B  download
29-Dec-14 Appendix 3B  download
19-Dec-14 Appendix 3B  download
19-Dec-14 ASX Announcement – SPP Update download
17-Dec-14 Clinical Validation Supporting BREVAGenplus in Breast Cancer Risk Assessment download
08-Dec-14 BBY Initiates Coverage  download
05-Dec-14
Appendix 3B download
05-Dec-14 ASX Announcement – Share Purchase Plan Document download
04-Dec-14 ASX Announcement – SPP – 2014 Cleansing Notice download
03-Dec-14 Appendix 3B and Options Cleansing Notice download
03-Dec-14 Appendix 3B and Convertible Note Cleansing Notice download
03-Dec-14 ASX Announcement – SPP Announcement – Dec-2014 download
24-Sep-14 Appointment of Independent Non-Executive Directors download
22-Sep-14 Divestment of Australian heritage business Commences Strategic Re-alignment download
15-Sep-14 Transformational restructuring plans to support Molecular Diagnostics focus and finalisation of financing download

All recent company announcements are listed in Announcements and News. To have these sent to you as they are announced, sign up to our email service.

For a further list of archived company announcements please visit the ASX website and type in ASX code GTG.

Full name (required)

Organisation

Email address (required)

Confirm email address (required)

Phone Number

Country

Enquiry details